Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET

[1]  Yue Huang,et al.  Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium , 2018, Neurology.

[2]  M. Kameyama,et al.  Cingulate island sign temporally changes in dementia with Lewy bodies , 2017, Scientific Reports.

[3]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[4]  H. Matsuda,et al.  Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT , 2017, Annals of Nuclear Medicine.

[5]  J. Graff‐Radford,et al.  18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies , 2017, The Journal of Nuclear Medicine.

[6]  T. Montine,et al.  Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis , 2017, The Lancet Neurology.

[7]  A. Drzezga,et al.  Elevated in vivo [18F]‐AV‐1451 uptake in a patient with progressive supranuclear palsy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[8]  David T. Jones,et al.  AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies , 2016, Annals of neurology.

[9]  H. Matsuda,et al.  The cingulate island sign within early Alzheimer’s disease-specific hypoperfusion volumes of interest is useful for differentiating Alzheimer’s disease from dementia with Lewy bodies , 2016, EJNMMI Research.

[10]  J. Armspach,et al.  Brain perfusion in dementia with Lewy bodies and Alzheimer’s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages , 2016, Alzheimer's Research & Therapy.

[11]  M. Kameyama,et al.  Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies , 2016, Annals of Nuclear Medicine.

[12]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[13]  Matthew L Senjem,et al.  Dementia with Lewy bodies , 2014, Neurology.

[14]  Mike P. Wattjes,et al.  Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies , 2014, European Radiology.

[15]  C. Jack,et al.  Multimodality imaging characteristics of dementia with Lewy bodies , 2012, Neurobiology of Aging.

[16]  C. Jack,et al.  Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies. , 2012, Brain : a journal of neurology.

[17]  John A Detre,et al.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. , 2012, Current opinion in neurology.

[18]  I. McKeith,et al.  Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study , 2012, The British journal of psychiatry : the journal of mental science.

[19]  Janet S. Reddin,et al.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.

[20]  Janet S. Reddin,et al.  Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease , 2011, Neurology.

[21]  D. Dickson,et al.  Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.

[22]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[23]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[24]  Gaohong Wu,et al.  Reliability and precision of pseudo‐continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O‐water PET in elderly subjects at risk for Alzheimer's disease , 2010, NMR in biomedicine.

[25]  Charles D. Smith,et al.  Low sensitivity in clinical diagnoses of dementia with Lewy bodies , 2010, Journal of Neurology.

[26]  Hengyi Rao,et al.  Arterial spin-labeled perfusion MRI in basic and clinical neuroscience , 2009, Current opinion in neurology.

[27]  D. Alsop,et al.  Continuous flow‐driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields , 2008, Magnetic resonance in medicine.

[28]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[29]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[30]  C. Miller,et al.  Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians , 2004, American journal of Alzheimer's disease and other dementias.

[31]  D W Dickson,et al.  DLB fluctuations , 2004, Neurology.

[32]  K. Jellinger.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2004, Neurology.

[33]  D. Jeste,et al.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.

[34]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[35]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[36]  Thomas E. Nichols,et al.  Comparative evaluation of MR-based partial-volume correction schemes for PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  Hiroaki Kazui,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography , 1997, Neuroscience Letters.

[38]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[39]  R. Buxton,et al.  A Model for the Coupling between Cerebral Blood Flow and Oxygen Metabolism during Neural Stimulation , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[41]  Donald S. Williams,et al.  Magnetic resonance imaging of perfusion using spin inversion of arterial water , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[43]  R. Daroff,et al.  The International Classification of Sleep Disorders , 1991, Neurology.